Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The practicalities of establishing a porcine isolated heart model.

Pavey W, Raisis A, Dunne B, Van Laeken E, Jenkinson C, Vincent V, Baird P, Prince S, Ho KM, Merry C, Gilfillan I.

Perfusion. 2018 Jul;33(5):363-366. doi: 10.1177/0267659117746232. Epub 2017 Dec 22.

PMID:
29272987
2.

Role of carbonic anhydrases in skin wound healing.

Barker H, Aaltonen M, Pan P, Vähätupa M, Kaipiainen P, May U, Prince S, Uusitalo-Järvinen H, Waheed A, Pastoreková S, Sly WS, Parkkila S, Järvinen TA.

Exp Mol Med. 2017 May 19;49(5):e334. doi: 10.1038/emm.2017.60.

3.

R-Ras deficiency does not affect papain-induced IgE production in mice.

Kummola L, Ortutay Z, Vähätupa M, Prince S, Uusitalo-Järvinen H, Järvinen TAH, Junttila IS.

Immun Inflamm Dis. 2017 Sep;5(3):280-288. doi: 10.1002/iid3.168. Epub 2017 May 11.

4.

T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development.

Vähätupa M, Aittomäki S, Martinez Cordova Z, May U, Prince S, Uusitalo-Järvinen H, Järvinen TA, Pesu M.

Oncoimmunology. 2016 Oct 14;5(12):e1245266. doi: 10.1080/2162402X.2016.1245266. eCollection 2016.

5.

Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.

Vähätupa M, Prince S, Vataja S, Mertimo T, Kataja M, Kinnunen K, Marjomäki V, Uusitalo H, Komatsu M, Järvinen TA, Uusitalo-Järvinen H.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4898-4909. doi: 10.1167/iovs.16-19212.

6.

Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.

Frago S, Nicholls RD, Strickland M, Hughes J, Williams C, Garner L, Surakhy M, Maclean R, Rezgui D, Prince SN, Zaccheo OJ, Ebner D, Sanegre S, Yu S, Buffa FM, Crump MP, Hassan AB.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):E2766-75. doi: 10.1073/pnas.1513023113. Epub 2016 May 2.

7.

Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition.

Järvinen TA, Prince S.

Biomed Res Int. 2015;2015:654765. doi: 10.1155/2015/654765. Epub 2015 Nov 30. Review.

8.

Systemically Administered, Target Organ-Specific Therapies for Regenerative Medicine.

Järvinen TA, May U, Prince S.

Int J Mol Sci. 2015 Sep 30;16(10):23556-71. doi: 10.3390/ijms161023556. Review.

9.

Resistance of R-Ras knockout mice to skin tumour induction.

May U, Prince S, Vähätupa M, Laitinen AM, Nieminen K, Uusitalo-Järvinen H, Järvinen TA.

Sci Rep. 2015 Jul 2;5:11663. doi: 10.1038/srep11663.

10.

An exon splice enhancer primes IGF2:IGF2R binding site structure and function evolution.

Williams C, Hoppe HJ, Rezgui D, Strickland M, Forbes BE, Grutzner F, Frago S, Ellis RZ, Wattana-Amorn P, Prince SN, Zaccheo OJ, Nolan CM, Mungall AJ, Jones EY, Crump MP, Hassan AB.

Science. 2012 Nov 30;338(6111):1209-13. doi: 10.1126/science.1228633.

11.

Developing a benchmarking process in perfusion: a report of the Perfusion Downunder Collaboration.

Baker RA, Newland RF, Fenton C, McDonald M, Willcox TW, Merry AF; Perfusion Downunder Collaboration.

J Extra Corpor Technol. 2012 Mar;44(1):26-33.

12.

Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.

Rezgui D, Williams C, Savage SA, Prince SN, Zaccheo OJ, Jones EY, Crump MP, Hassan AB.

J Mol Endocrinol. 2009 Apr;42(4):341-56. doi: 10.1677/JME-08-0154. Epub 2009 Feb 10.

13.

Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11.

Williams C, Rezgui D, Prince SN, Zaccheo OJ, Foulstone EJ, Forbes BE, Norton RS, Crosby J, Hassan AB, Crump MP.

Structure. 2007 Sep;15(9):1065-78.

14.
15.

Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.

Zaccheo OJ, Prince SN, Miller DM, Williams C, Kemp CF, Brown J, Jones EY, Catto LE, Crump MP, Hassan AB.

J Mol Biol. 2006 Jun 2;359(2):403-21. Epub 2006 Apr 6.

PMID:
16631789
16.

Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression.

Richardson C, Brennan P, Powell M, Prince S, Chen YH, Spiller OB, Rowe M.

J Gen Virol. 2005 Jun;86(Pt 6):1669-79.

PMID:
15914844
17.

Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

Prince S, Keating S, Fielding C, Brennan P, Floettmann E, Rowe M.

J Virol. 2003 Apr;77(8):5000-7.

Supplemental Content

Loading ...
Support Center